Medical - Diagnostics & Research
Compare Stocks
2 / 10Stock Comparison
STRR vs HCSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
STRR vs HCSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Care Facilities |
| Market Cap | $30M | $1.58B |
| Revenue (TTM) | $114M | $1.84B |
| Net Income (TTM) | $-6M | $59M |
| Gross Margin | 40.9% | 13.3% |
| Operating Margin | -1.0% | 3.0% |
| Forward P/E | — | 20.6x |
| Total Debt | $1M | $25M |
| Cash & Equiv. | $17M | $161M |
STRR vs HCSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Star Equity Holding… (STRR) | 100 | 108.5 | +8.5% |
| Healthcare Services… (HCSG) | 100 | 92.3 | -7.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STRR vs HCSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STRR is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.19, yield 6.9%
- 53.8% 10Y total return vs HCSG's -27.0%
- Lower volatility, beta 0.19, Low D/E 2.6%, current ratio 3.58x
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs STRR's -66.9%
- 3.2% margin vs STRR's -5.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs STRR's -66.9% | |
| Quality / Margins | 3.2% margin vs STRR's -5.4% | |
| Stability / Safety | Beta 0.19 vs HCSG's 1.12, lower leverage | |
| Dividends | 6.9% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +53.4% vs STRR's -5.5% | |
| Efficiency (ROA) | 7.3% ROA vs STRR's -8.7%, ROIC 9.0% vs -24.3% |
STRR vs HCSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
STRR vs HCSG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HCSG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HCSG is the larger business by revenue, generating $1.8B annually — 16.2x STRR's $114M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to STRR's -5.4%. On growth, STRR holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $114M | $1.8B |
| EBITDAEarnings before interest/tax | $2M | $72M |
| Net IncomeAfter-tax profit | -$6M | $59M |
| Free Cash FlowCash after capex | -$10M | $139M |
| Gross MarginGross profit ÷ Revenue | +40.9% | +13.3% |
| Operating MarginEBIT ÷ Revenue | -1.0% | +3.0% |
| Net MarginNet income ÷ Revenue | -5.4% | +3.2% |
| FCF MarginFCF ÷ Revenue | -8.4% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +6.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +175.0% |
Valuation Metrics
STRR leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $30M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $14M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -2.37x | 27.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.61x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 22.12x |
| Price / SalesMarket cap ÷ Revenue | 0.55x | 0.86x |
| Price / BookPrice ÷ Book value/share | 0.73x | 3.16x |
| Price / FCFMarket cap ÷ FCF | — | 11.36x |
Profitability & Efficiency
HCSG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-13 for STRR. STRR carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to HCSG's 0.05x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs STRR's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -13.0% | +11.8% |
| ROA (TTM)Return on assets | -8.7% | +7.3% |
| ROICReturn on invested capital | -24.3% | +9.0% |
| ROCEReturn on capital employed | -18.5% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 0.03x | 0.05x |
| Net DebtTotal debt minus cash | -$16M | -$136M |
| Cash & Equiv.Liquid assets | $17M | $161M |
| Total DebtShort + long-term debt | $1M | $25M |
| Interest CoverageEBIT ÷ Interest expense | -47.19x | 33.02x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,863 today (with dividends reinvested), compared to $5,171 for STRR. Over the past 12 months, HCSG leads with a +53.4% total return vs STRR's -5.5%. The 3-year compound annual growth rate (CAGR) favors HCSG at 13.7% vs STRR's -25.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.9% | +27.2% |
| 1-Year ReturnPast 12 months | -5.5% | +53.4% |
| 3-Year ReturnCumulative with dividends | -58.2% | +47.0% |
| 5-Year ReturnCumulative with dividends | -48.3% | -21.4% |
| 10-Year ReturnCumulative with dividends | +53.8% | -27.0% |
| CAGR (3Y)Annualised 3-year return | -25.2% | +13.7% |
Risk & Volatility
Evenly matched — STRR and HCSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
STRR is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 90.5% from its 52-week high vs STRR's 78.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.19x | 1.12x |
| 52-Week HighHighest price in past year | $11.99 | $24.39 |
| 52-Week LowLowest price in past year | $1.99 | $12.66 |
| % of 52W HighCurrent price vs 52-week peak | +78.4% | +90.5% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 59.7 |
| Avg Volume (50D)Average daily shares traded | 7K | 676K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
STRR is the only dividend payer here at 6.90% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $24.50 |
| # AnalystsCovering analysts | — | 15 |
| Dividend YieldAnnual dividend ÷ price | +6.9% | — |
| Dividend StreakConsecutive years of raises | 1 | 20 |
| Dividend / ShareAnnual DPS | $0.65 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.9% | +3.9% |
HCSG leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). STRR leads in 1 (Valuation Metrics). 1 tied.
STRR vs HCSG: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is STRR or HCSG a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -66. 9% for Star Equity Holdings, Inc. (STRR). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 2x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Healthcare Services Group, Inc. (HCSG) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — STRR or HCSG?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 4%, compared to -48. 3% for Star Equity Holdings, Inc. (STRR). Over 10 years, the gap is even starker: STRR returned +53. 8% versus HCSG's -27. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — STRR or HCSG?
By beta (market sensitivity over 5 years), Star Equity Holdings, Inc.
(STRR) is the lower-risk stock at 0. 19β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 486% more volatile than STRR relative to the S&P 500. On balance sheet safety, Star Equity Holdings, Inc. (STRR) carries a lower debt/equity ratio of 3% versus 5% for Healthcare Services Group, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — STRR or HCSG?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -66. 9% for Star Equity Holdings, Inc. (STRR). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -257. 7% for Star Equity Holdings, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — STRR or HCSG?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -19. 6% for Star Equity Holdings, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -15. 8% for STRR. At the gross margin level — before operating expenses — STRR leads at 20. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — STRR or HCSG?
In this comparison, STRR (6.
9% yield) pays a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.
07Is STRR or HCSG better for a retirement portfolio?
For long-horizon retirement investors, Star Equity Holdings, Inc.
(STRR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 19), 6. 9% yield). Both have compounded well over 10 years (STRR: +53. 8%, HCSG: -27. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between STRR and HCSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: STRR is a small-cap income-oriented stock; HCSG is a small-cap quality compounder stock. STRR pays a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.